Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
Bristol-Myers Squibb
Kim Papp; Kenneth Gordon; Diamant Thaçi; Akimichi Morita; Melinda Gooderham; Peter Foley; Ihab G Girgis; Sudeep Kundu; Subhashis Banerjee